USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Explore Potential Partners and Distribution Channels to Increase Market Position in the Direct-to-Consumer Pathway
12-Sep-2016
North America
Market Research
9AB9-00-17-00-00
HC02675-NA-MR_18986
The objective of this research is to understand the food intolerance and food allergy testing market in the United States. While allergy testing is common, food intolerance testing is provided by very few manufacturers, mostly as laboratory developed tests (LDTs) in the direct-to-consumer (DTC) pathway. The study includes key profiles of food intolerance testing vendors, DTC portals for allergy and intolerance tests, test volume analysis of intolerance testing, and key allergy tests (using relevant CPT codes). Test revenue/unit price estimates for the market are calculated based on the Part B National Summary Analysis for ALCAT tests, blood-based (IgE) and skin tests. The relevant CPT codes are provided. The study period is 2015 to 2019.
Key Findings
Market Scope
Food Allergy vs. Food Intolerance Testing
Major Allergens
Value Chain of the Food Intolerance and Allergy Testing Market
Overall Competitive Landscape
Overall Competitive Landscape (continued)
Company Profile—Cell Science Systems
Product Analysis
Company Profile—Genova Diagnostics
Product Analysis
Company Profile—Cyrex Laboratories
Product Analysis
Company Profile—Any Lab Test Now
Company Profile—Request A Test
Company Profile—DirectLabs
Potential Partners for DTC and Allergy Clinics to Seek Partnerships
Revenue Forecast
Food Intolerance Testing Medicare Test Volume Analysis
Food Intolerance Testing Medicare Test Volume Analysis (continued)
Food Allergy Testing Medicare Test Volume Analysis
Food Allergy Testing Medicare Test Volume Analysis (continued)
Food Allergy Testing Medicare Test Volume Analysis (continued)
Food Allergy Testing Medicare Test Volume Analysis (continued)
Regulations and Threats
Basic Checklist of Attack Strategies
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related In Vitro Diagnostics (IVD) research
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
25 Aug 2026 | Global | Technology Research
Breakthrough Innovations in Point-of-Care Diagnostics
This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, ...
21 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease...
07 Aug 2026 | Global | Customer Research
Laboratory Product Purchasing Trends, United States and Europe, 2025–2026
Qualified respondents to this Frost & Sullivan survey were invited to participate in an online survey examining their laboratory’s product purchasing process in 2025 and expectations for 2026. Frost & Sullivan has conducted similar studies among the same target respondent groups since 2012. The surv...
21 Jul 2026 | Global | Market Research
Point-of-Care Testing Market, Global, 2024–2031
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized ...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Divyaa Ravishankar |
| Industries | Healthcare |
| WIP Number | 9AB9-00-17-00-00 |
| Is Prebook | No |
Analysis of US Food Intolerance and Allergy Testing Market
$1,500.00
Special Price $1,125.00 save 25 %